HOME >> BIOLOGY >> NEWS
AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research

WASHINGTON, D.C.-AAAS has welcomed efforts by Washington state legislators to pass a bill banning reproductive cloning in the state while allowing research on human embryonic stem cells.

In letters sent to two sponsors of the bill, Alan I. Leshner, the chief executive officer of AAAS and executive publisher of the journal Science, reaffirmed the association's position that cloning to extract stem cells from early-stage human embryos for research purposes "holds great promise." But he also noted that "the benefits will only be realized through carefully designed research" that is subject to appropriate ethical and legal oversight. And he reiterated that AAAS has endorsed a legal ban on any efforts to clone human embryos to produce babies.

Leshner's letter was faxed Monday 28 March 28 2005 as a committee of the Washington State Senate holds a hearing on the bill, which already has been approved by the state's House of Representatives. The letter was sent to state Rep. Shay Schual-Berke, a physician and sponsor of the bill in the House, and state Sen. Jeanne Kohl-Welles, a co-sponsor in the Senate who has a Ph.D. in sociology. Both are Democrats.

The bill includes some specific ethical guidelines, such as the patient's right to full disclosure and civil penalties for reproductive cloning.

Legislators in several states, including Maryland, have attempted to follow the lead of California in backing stem cell research that President George W. Bush restricted at the federal level in 2001. In Congress, the House leadership reportedly has agreed to allow a floor vote this session on a proposal to ease the federal restrictions and allow study of newer stem cell lines derived from embryos discarded by fertility clinics.

[For more information, read the full letter. ]


'"/>


29-Mar-2005


Page: 1

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner registers strong concerns over suppression of science films
4. AAAS CEO Alan I. Leshner statement on the UN cloning debate
5. National Inventors Hall of Fame welcomes 2005 inductees
6. BioMed Central welcomes the new National Institutes of Health public access policy
7. Telemedicine initiative for sub-Saharan Africa: Pilot projects proposed
8. Major initiative proposed to address amphibian crisis
9. AIDS research agenda proposed
10. New model of p53 regulation proposed that suggests novel anticancer strategy
11. Mechanism proposed for link between RU-486 and fatal infections

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/25/2016)... Unisys Corporation (NYSE: UIS ) today announced the implementation ... New York City , to help U.S. ... the United States using passports that are ... of the system at Dulles last year. The system will ... 2016. --> pilot testing of the system at ...
(Date:1/22/2016)... , January 22, 2016 ... the addition of the  "Global Behavioral ... offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ... "Global Behavioral Biometric Market 2016-2020"  report ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... Amarantus BioScience Holdings, Inc. ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, ... (RPDD) from the US Food and Drug Administration (FDA) ... previously granted orphan drug designation (ODD) by the US ... Holdings, Inc. (OTCQB: AMBS), a biotechnology ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
Breaking Biology Technology:
Cached News: